CVE-2017-18013

Public Exploit

Description

In LibTIFF 4.0.9, there is a Null-Pointer Dereference in the tif_print.c TIFFPrintDirectory function, as demonstrated by a tiffinfo crash.

Category

6.5
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.43%
Vendor Advisory ubuntu.com Vendor Advisory ubuntu.com Vendor Advisory debian.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://lists.debian.org/debian-lts-announce/2018/01/msg00033.html mailing list
https://usn.ubuntu.com/3606-1/ vendor advisory
https://lists.debian.org/debian-lts-announce/2018/01/msg00034.html mailing list
https://gitlab.com/libtiff/libtiff/commit/c6f41df7b581402dfba3c19a1e3df4454c551a01 patch
https://usn.ubuntu.com/3602-1/ vendor advisory
http://www.securityfocus.com/bid/102345 vdb entry third party advisory
https://www.debian.org/security/2018/dsa-4100 vendor advisory
http://bugzilla.maptools.org/show_bug.cgi?id=2770 issue tracking patch exploit third party advisory

Frequently Asked Questions

What is the severity of CVE-2017-18013?
CVE-2017-18013 has been scored as a medium severity vulnerability.
How to fix CVE-2017-18013?
To fix CVE-2017-18013, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-18013 being actively exploited in the wild?
It is possible that CVE-2017-18013 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.